Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial

{ 'indexed': {'date-parts': [[2024, 4, 8]], 'date-time': '2024-04-08T20:30:05Z', 'timestamp': 1712608205867}, 'reference-count': 35, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2021, 7, 1]], 'date-time': '2021-07-01T00:00:00Z', 'timestamp': 1625097600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 5, 26]], 'date-time': '2021-05-26T00:00:00Z', 'timestamp': 1621987200000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://creativecommons.org/licenses/by-nc-nd/4.0/'}], 'content-domain': { 'domain': ['thelancet.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2021, 7]]}, 'DOI': '10.1016/j.eclinm.2021.100959', 'type': 'journal-article', 'created': {'date-parts': [[2021, 6, 18]], 'date-time': '2021-06-18T03:31:21Z', 'timestamp': 1623987081000}, 'page': '100959', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 63, 'title': 'Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized ' 'trial', 'prefix': '10.1016', 'volume': '37', 'author': [ { 'ORCID': 'http://orcid.org/0000-0001-9054-1211', 'authenticated-orcid': False, 'given': 'Alejandro', 'family': 'Krolewiecki', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0001-7605-9744', 'authenticated-orcid': False, 'given': 'Adrián', 'family': 'Lifschitz', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-6897-5950', 'authenticated-orcid': False, 'given': 'Matías', 'family': 'Moragas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marina', 'family': 'Travacio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ricardo', 'family': 'Valentini', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel F.', 'family': 'Alonso', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rubén', 'family': 'Solari', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcelo A.', 'family': 'Tinelli', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-4253-9077', 'authenticated-orcid': False, 'given': 'Rubén O.', 'family': 'Cimino', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luis', 'family': 'Álvarez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pedro E.', 'family': 'Fleitas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Ceballos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marcelo', 'family': 'Golemba', 'sequence': 'additional', 'affiliation': []}, {'given': 'Florencia', 'family': 'Fernández', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Diego', 'family': 'Fernández de Oliveira', 'sequence': 'additional', 'affiliation': []}, {'given': 'German', 'family': 'Astudillo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Inés', 'family': 'Baeck', 'sequence': 'additional', 'affiliation': []}, {'given': 'Javier', 'family': 'Farina', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-4751-5485', 'authenticated-orcid': False, 'given': 'Georgina A.', 'family': 'Cardama', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea', 'family': 'Mangano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eduardo', 'family': 'Spitzer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Silvia', 'family': 'Gold', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carlos', 'family': 'Lanusse', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.eclinm.2021.100959_bib0001', 'series-title': 'COVID-19 treatment guidelines panel. Coronavirus disease 2019 (COVID-19) ' 'treatment guidelines', 'year': '2020'}, { 'issue': '95', 'key': '10.1016/j.eclinm.2021.100959_bib0002', 'first-page': '469', 'article-title': 'World Health Organization. Summary of global update on implementation ' 'of preventive chemotherapy against neglected tropical diseases in 2019', 'volume': '39', 'year': '2020', 'journal-title': 'Wkly Epiemiol Rec'}, { 'issue': '9', 'key': '10.1016/j.eclinm.2021.100959_bib0003', 'doi-asserted-by': 'crossref', 'first-page': '2100', 'DOI': '10.3390/cells9092100', 'article-title': 'Ivermectin as a broad-spectrum host-directed antiviral: the real deal?', 'volume': '9', 'author': 'Jans', 'year': '2020', 'journal-title': 'Cells'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0004', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.antiviral.2020.104787', 'article-title': 'The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 ' 'in vitro', 'volume': '178', 'author': 'Caly', 'year': '2020', 'journal-title': 'Antivir Res'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0005', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fphar.2021.625678', 'article-title': 'Modeling of SARS-CoV-2 treatment effects for informed drug repurposing', 'volume': '12', 'author': 'Kern', 'year': '2021', 'journal-title': 'Front Pharmacol'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0006', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jama.2021.3071', 'article-title': 'Effect of Ivermectin on time to resolution of symptoms among adults ' 'with mild COVID-19: a randomized clinical trial', 'author': 'López-Medina', 'year': '2021', 'journal-title': 'JAMA'}, { 'issue': '1', 'key': '10.1016/j.eclinm.2021.100959_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '161', 'DOI': '10.1186/s12936-017-1801-4', 'article-title': 'Ivermectin to reduce malaria transmission I. Pharmacokinetic and ' 'pharmacodynamic considerations regarding efficacy and safety', 'volume': '16', 'author': 'Chaccour', 'year': '2017', 'journal-title': 'Malar J'}, { 'issue': '4', 'key': '10.1016/j.eclinm.2021.100959_bib0008', 'doi-asserted-by': 'crossref', 'first-page': '827', 'DOI': '10.1093/jac/dkz524', 'article-title': 'Safety of high-dose ivermectin: a systematic review and meta-analysis', 'volume': '75', 'author': 'Navarro', 'year': '2020', 'journal-title': 'J Antimicrob Chemother'}, { 'issue': '6', 'key': '10.1016/j.eclinm.2021.100959_bib0009', 'doi-asserted-by': 'crossref', 'first-page': '615', 'DOI': '10.1016/S1473-3099(18)30163-4', 'article-title': 'Safety and mosquitocidal efficacy of high-dose ivermectin when ' 'co-administered with dihydroartemisinin-piperaquine in Kenyan adults ' 'with uncomplicated malaria (IVERMAL): a randomised, double-blind, ' 'placebo-controlled trial', 'volume': '18', 'author': 'Smit', 'year': '2018', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '10', 'key': '10.1016/j.eclinm.2021.100959_bib0010', 'doi-asserted-by': 'crossref', 'first-page': '1122', 'DOI': '10.1177/009127002237994', 'article-title': 'Safety, tolerability, and pharmacokinetics of escalating high doses of ' 'ivermectin in healthy adult subjects', 'volume': '42', 'author': 'Guzzo', 'year': '2002', 'journal-title': 'J Clin Pharmacol'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '42', 'DOI': '10.1208/s12248-007-9000-9', 'article-title': 'The pharmacokinetics and interactions of ivermectin in humans - a mini ' 'review', 'volume': '10', 'author': 'González Canga', 'year': '2008', 'journal-title': 'AAPS J'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0012', 'first-page': 'ciab365', 'article-title': 'Efficacy and safety of albendazole and high-dose ivermectin ' 'co-administration in school-aged children infected with Trichuris ' 'trichiura in Honduras: A Randomized Controlled Trial', 'author': 'Matamoros', 'year': '2021', 'journal-title': 'Clin Infect Dis'}, { 'issue': '2', 'key': '10.1016/j.eclinm.2021.100959_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '165', 'DOI': '10.1016/S1473-3099(20)30424-2', 'article-title': 'RT-PCR for SARS-CoV-2:quantitative versus qualitative', 'volume': '21', 'author': 'Han', 'year': '2021', 'journal-title': 'Lancet Infect Dis'}, { 'issue': '3', 'key': '10.1016/j.eclinm.2021.100959_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '550', 'DOI': '10.1128/CMR.00074-09', 'article-title': 'Validation of laboratory-developed molecular assays for infectious ' 'diseases', 'volume': '23', 'author': 'Burd', 'year': '2010', 'journal-title': 'Clin Microbiol Rev'}, { 'issue': '4', 'key': '10.1016/j.eclinm.2021.100959_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '611', 'DOI': '10.1373/clinchem.2008.112797', 'article-title': 'The MIQE guidelines: minimum information for publication of ' 'quantitative real-time PCR experiments', 'volume': '55', 'author': 'Bustin', 'year': '2009', 'journal-title': 'Clin Chem'}, { 'issue': '4', 'key': '10.1016/j.eclinm.2021.100959_bib0016', 'doi-asserted-by': 'crossref', 'first-page': '327', 'DOI': '10.1016/S0304-4017(99)00175-2', 'article-title': 'Comparative distribution of ivermectin and doramectin to parasite ' 'location tissues in cattle', 'volume': '87', 'author': 'Lifschitz', 'year': '2000', 'journal-title': 'Vet Parasitol'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0017', 'series-title': 'Pharmacokinetics', 'author': 'Gibaldi', 'year': '1982'}, { 'issue': '23–24', 'key': '10.1016/j.eclinm.2021.100959_bib0018', 'doi-asserted-by': 'crossref', 'first-page': '2455', 'DOI': '10.1002/sim.4780132309', 'article-title': 'Internal pilot studies for estimating sample size', 'volume': '13', 'author': 'Birkett', 'year': '1994', 'journal-title': 'Stat Med'}, { 'issue': '2', 'key': '10.1016/j.eclinm.2021.100959_bib0019', 'doi-asserted-by': 'crossref', 'first-page': '197', 'DOI': '10.1016/j.jclinepi.2012.09.002', 'article-title': 'Sample size calculations for pilot randomized trials: a confidence ' 'interval approach', 'volume': '66', 'author': 'Cocks', 'year': '2013', 'journal-title': 'J Clin Epidemiol'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0020', 'series-title': 'Statistical power analysis for the behavioral sciences', 'author': 'Cohen', 'year': '1988'}, { 'issue': '6', 'key': '10.1016/j.eclinm.2021.100959_bib0021', 'doi-asserted-by': 'crossref', 'first-page': 'E882', 'DOI': '10.1152/ajpendo.00178.2020', 'article-title': 'COVID-19-associated SIADH\xa0: a clue in the times of pandemic!', 'volume': '318', 'author': 'Yousaf', 'year': '2020', 'journal-title': 'Am J Physiol Endocrinol Metab'}, { 'issue': '6', 'key': '10.1016/j.eclinm.2021.100959_bib0022', 'doi-asserted-by': 'crossref', 'first-page': '1156', 'DOI': '10.4269/ajtmh.20-0271', 'article-title': 'Ivermectin and COVID-19\xa0: keeping rigor in times of urgency', 'volume': '102', 'author': 'Chaccour', 'year': '2020', 'journal-title': 'Am J Trop Med Hyg'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0023', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.xphs.2021.01.017', 'article-title': 'Safety and pharmacokinetic assessments of a novel ivermectin nasal ' 'spray formulation in a pig model', 'author': 'Errecalde', 'year': '2021', 'journal-title': 'J Pharm Sci'}, { 'issue': '12', 'key': '10.1016/j.eclinm.2021.100959_bib0024', 'doi-asserted-by': 'crossref', 'first-page': '3574', 'DOI': '10.1016/j.xphs.2020.08.024', 'article-title': 'Development of a minimal physiologically-based pharmacokinetic model to ' 'simulate lung exposure in humans following oral administration of ' 'ivermectin for COVID-19 drug repurposing', 'volume': '109', 'author': 'Jermain', 'year': '2020', 'journal-title': 'J Pharm Sci'}, { 'issue': '10236', 'key': '10.1016/j.eclinm.2021.100959_bib0025', 'doi-asserted-by': 'crossref', 'first-page': '1569', 'DOI': '10.1016/S0140-6736(20)31022-9', 'article-title': 'Remdesivir in adults with severe COVID-19: a randomised, double-blind, ' 'placebo-controlled, multicentre trial', 'volume': '395', 'author': 'Wang', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0026', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.eclinm.2020.100720', 'article-title': 'The effect of early treatment with ivermectin on viral load, symptoms ' 'and humoral response in patients with non-severe COVID-19: a pilot, ' 'double-blind, placebo-controlled, randomized clinical trial', 'volume': '32', 'author': 'Chaccour', 'year': '2021', 'journal-title': 'EClinicalMedicine'}, { 'issue': '1', 'key': '10.1016/j.eclinm.2021.100959_bib0027', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pntd.0006020', 'article-title': 'Safety and pharmacokinetic profile of fixed-dose ivermectin with an ' 'innovative 18mg tablet in healthy adult volunteers', 'volume': '12', 'author': 'Muñoz', 'year': '2018', 'journal-title': 'PLoS Negl Trop Dis'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0028', 'first-page': '84', 'article-title': 'Interaction of macrocyclic lactones with P-glycoprotein\xa0: ' 'structure–affinity relationship', 'volume': '0', 'author': 'Lespine', 'year': '2006', 'journal-title': 'Eur J Pharm Sci'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0029', 'doi-asserted-by': 'crossref', 'first-page': '242', 'DOI': '10.1111/j.1365-2885.2007.00848.x', 'article-title': 'Involvement of P-glycoprotein on ivermectin kinetic behaviour in ' 'sheep\xa0: itraconazole-mediated changes on gastrointestinal ' 'disposition', 'author': 'Ballent', 'year': '2007', 'journal-title': 'J Vet Pharmacol Ther'}, { 'issue': '7', 'key': '10.1016/j.eclinm.2021.100959_bib0030', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0158237', 'article-title': 'How can viral dynamics models inform endpoint measures in clinical ' 'trials of therapies for acute viral infections?', 'volume': '11', 'author': 'Vegvari', 'year': '2016', 'journal-title': 'PLoS ONE'}, { 'issue': '6', 'key': '10.1016/j.eclinm.2021.100959_bib0031', 'doi-asserted-by': 'crossref', 'DOI': '10.1371/journal.pone.0156622', 'article-title': 'Using clinical trial simulators to analyse the sources of variance in ' 'clinical trials of novel therapies for acute viral infections', 'volume': '11', 'author': 'Vegvari', 'year': '2016', 'journal-title': 'PLoS ONE'}, { 'issue': '17', 'key': '10.1016/j.eclinm.2021.100959_bib0032', 'doi-asserted-by': 'crossref', 'first-page': '1645', 'DOI': '10.1056/NEJMoa2015294', 'article-title': 'Interferon beta-1b and lopinavir–ritonavir for middle east respiratory ' 'syndrome', 'volume': '383', 'author': 'Arabi', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'issue': '7809', 'key': '10.1016/j.eclinm.2021.100959_bib0033', 'doi-asserted-by': 'crossref', 'first-page': '465', 'DOI': '10.1038/s41586-020-2196-x', 'article-title': 'Virological assessment of hospitalized patients with COVID-2019', 'volume': '581', 'author': 'Wölfel', 'year': '2020', 'journal-title': 'Nature'}, { 'key': '10.1016/j.eclinm.2021.100959_bib0034', 'doi-asserted-by': 'crossref', 'first-page': '16222', 'DOI': '10.1038/srep16222', 'article-title': 'Modulation of P2X4 /P2X7 / Pannexin-1 sensitivity to extracellular ATP ' 'via Ivermectin induces a non-apoptotic and inflammatory form of cancer ' 'cell death', 'volume': '5', 'author': 'Draganov', 'year': '2015', 'journal-title': 'Sci Rep'}, { 'issue': '3', 'key': '10.1016/j.eclinm.2021.100959_bib0035', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.106125', 'article-title': 'Repurposing of host-based therapeutic agents for the treatment of ' 'coronavirus disease 2019 (COVID-19): a link between antiviral and ' 'anticancer mechanisms?', 'volume': '56', 'author': 'Alonso', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}], 'container-title': 'eClinicalMedicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S258953702100239X?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S258953702100239X?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 12, 14]], 'date-time': '2022-12-14T08:14:07Z', 'timestamp': 1671005647000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S258953702100239X'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 7]]}, 'references-count': 35, 'alternative-id': ['S258953702100239X'], 'URL': 'http://dx.doi.org/10.1016/j.eclinm.2021.100959', 'relation': {}, 'ISSN': ['2589-5370'], 'subject': ['General Medicine'], 'container-title-short': 'eClinicalMedicine', 'published': {'date-parts': [[2021, 7]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Antiviral effect of high-dose ivermectin in adults with COVID-19: A ' 'proof-of-concept randomized trial', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'eClinicalMedicine', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.eclinm.2021.100959', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 The Author(s). Published by Elsevier Ltd.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '100959'}